Rosetta Biosoftware Introduces the Rosetta Resolver® Gene Expression Data Analysis System Version 7.0

SEATTLE–(BUSINESS WIRE)–Rosetta Biosoftware today introduced the Rosetta Resolver® gene expression data analysis system 7.0, with capabilities to promote standardized data storage and exchange. The new version will be presented at the Rosetta Technology Forum, the first of four taking place this year, held immediately prior to the Society of Toxicology annual meeting on March 24, 2007, in Charlotte, North Carolina. The new Resolver system version 7.0 also provides support for endpoint data storage in the Clinical Data Interchange Standards Consortium’s (CDISC) Standard for Exchange of Non-clinical Data (SEND) format and additional gene expression platforms, such as the Illumina® platform.

“The Resolver system 7.0 provides our customers with clear-cut ways to exchange data and enrich their gene expression experiments,” said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware. “We developed this version to facilitate data exchange with the FDA and to enable collaborations for our customers.”

A data repository is now available in the Resolver system 7.0 for endpoint data, allowing researchers to visualize and analyze data in the CDISC’s SEND format along with gene expression data. Other data types that can be stored and incorporated in the Resolver system 7.0 include Laboratory Information Management Systems (LIMS) and quality control data. Additional gene expression array platforms, such as the Illumina platform, are supported by the Resolver system 7.0.

Further information will be presented at the upcoming Rosetta Technology Forum in Charlotte, North Carolina, on March 24. To register for this conference, visit http://www.rosettabio.com/conferences/charlotte/default.asp.

About the Rosetta Resolver System

The Rosetta Resolver system is a high-capacity data storage, retrieval, and analysis solution for gene expression data. The system is ideal for life science research organizations that need to assess compound specificity or toxicity, identify new genes or therapeutic targets or compare and analyze large databases of expression profiles. The Rosetta Resolver system combines flexibility and ease of use with high-performance algorithms to produce a comprehensive solution for rapid analysis of gene expression data. The Rosetta Resolver system can accept and analyze data from a wide variety of expression profiling formats, and applies Rosetta Biosoftwares proprietary error models to yield quality statistics for every gene expression measurement within the system. These statistics are automatically leveraged by Rosetta Resolver system analysis tools for optimal results.

Life science research organizations that have licensed the Rosetta Resolver system include many of the top pharmaceutical companies in the world, such as Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., Inc., and Sanofi-Aventis, as well as premier academic institutions such as the Harvard University Center for Genomics Research and the California Institute of Technology. Additional information about the Rosetta Resolver system can be found on the Rosetta Biosoftware Web site at www.rosettabio.com.

About Rosetta Biosoftware

Rosetta Biosoftware is a leading provider of informatics solutions for life science research. Its comprehensive software solutions, including the Rosetta Resolver and Rosetta Elucidator systems, empower life scientists with advanced, scalable, and easy-to-use analysis platforms that accelerate discovery research. Rosetta Biosoftware is a business unit of Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc. (NYSE:MRK). More information about Rosetta Biosoftware is available at www.rosettabio.com.

Rosetta Resolver and Elucidator are U.S. registered trademarks of Rosetta Inpharmatics LLC.